Brief: Mannkind Corporation Reports 2022 Fourth Quarter And Full Year Financial Results
23/02/2023 23:50
Feb 23 (Reuters) - Mannkind Corp MNKD.O :
* ORATION REPORTS 2022 FOURTH QUARTER AND FULL YEAR
FINANCIAL
RESULTS
* QTRLY LOSS PER SHARE OF $0.07
* Q4 EARNINGS PER SHARE VIEW $-0.06 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbFS5qR
Further company coverage: MNKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children